Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway
Summary: Novavax reported a net loss of $0.76/share and $84.5M in revenue, beating estimates but cutting guidance due to...
Tag: NVAX
Novavax Q3 Earnings A Week Away – Time To Accept A New Reality
Summary: Novavax' Q3 earnings are due on 6th November.The vaccine developer was part of Operation Warp Speed, receiving...
Novavax: Lack Of Sustainable Revenue Growth Is A Problem
Summary: Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi, boosting its...
Novavax’s Future Hinges On Sanofi Deal And Upcoming Milestones
Summary: Novavax has secured a transformative partnership with Sanofi, which includes $1.2 billion in potential payments...
Novavax: Staying Long Despite Coming Up Short In Q2
Summary: Novavax reported Q2 earnings with a miss on EPS and revenue, causing a drop in share price, but recovered after...
Novavax Ahead Of Q2 Earnings – Picking Apart The Sanofi Deal
Summary: Novavax's Q1 2024 earnings were so-so, but a major partnership with Sanofi sent its share price soaring by...
Novavax: New Chapter, Questions Remain
Summary: Novavax, Inc. secured a lucrative deal with Sanofi, receiving potentially $1.2 billion in cash and future...
Novavax: Bird Flu And COVID-19 Headlines Trigger Rally
Summary: Novavax has seen a surge in stock price due to recent COVID-19 and bird flu vaccine developments, reaching over...
Novavax: Sanofi Partnership Revitalizes My Magnum Opus
Summary: Novavax announced Q1 2024 results with a beat on EPS and a miss on revenue, causing a surge in premarket...
Novavax Ditches ‘Going Concern,’ Embraces Sanofi Safety Net (Rating Upgrade)
Summary: Novavax, Inc.'s Sanofi partnership provides much-needed financial support via upfront and milestone payments,...